This is the same asshole that writes ten times a day (usually with about 5 mins between post as if it isn't obvious enough) and keeps writing about how the collapse is coming or patients are dying due to recalls or whistleblowers are calling or something of the like. All wishful thinking. All the same jackass that has no clue what they are talking about. "I heard callas are being made". Classic. As if someone secretly blowing the whistle goes and tells a bunch of people.
Sounds to me as if you is management buddy keeping track of this person. Why you worried? Let them have their say who cares?
Actually don't work at Valeant. I originally came here because I considered an opportunity with Valeant. Just been reading the same thing for months on here and it's obvious it's the same person with a vendetta. None of the predictions have come true which isn't to say they won't. But this person keeps acting like tomorrow is the day. The schtick is getting old and you are destroying the credibility of any real information on this board.
Completely agree with posts #5 and #9. The mindless postings of the "gloom and doom" troll has grown tiresome. Hopefully the troll gets a job somewhere else and moves on.
You'd fit right in with management..... How come you're still here man? Let it go dude some of the stuff that's happening inside this company is nothing short of scandalous
Running a tight ship has other downsides. Employees get laid off frequently, as Valeant integrates its latest acquisition, and high turnover reduces institutional memory. It also results in promotions of executives who are less ready to take on their responsibilities, current and former employees say, and executives are often reluctant to raise concerns about problems. "Nobody will object to anything," said a former executive who requested anonymity to preserve her employment opportunities within the industry. "They are too busy. And they are worried about being laid off." The company counters that its top management ranks are stronger than ever and that internal surveys show morale is high. One victim of Valeant's thin staffing was Jublia, a drug to treat toenail fungus, the current and former executives say. The market for the drug is estimated to be worth as much as $800 million a year. Jublia ran into manufacturing problems. Some bottles were leaking, and the F.D.A. was concerned. Again, Valeant took an aggressive tack with the regulator, downplaying the severity of the problem, according to people I spoke with. In the middle of last year, the F.D.A. declined to approve the treatment. Some executives believe that if the company had not been so thinly staffed, experts would have been able to find a solution to the problem more quickly or fix it before the F.D.A. turned down the application, resulting in a lengthier delay. "It's a prime example of not having a great set of expertise or enough time to look into the submission documents," a former employee said.
Mostly true. Especially about the loss of institutional knowledge to fix Jublia. The part about execs being afraid to speak up is nonsense. Most don't care unless it keeps them from shipping product. Even then they only care enough to go through the motions so they can ship. The only thing they care about is meeting the budget cuts that Pearson demands.
Not if you believe all the crap posted on this board. There's a fairly active troll with an axe to grind. Probably lost his job because he couldn't cut it.